221 related articles for article (PubMed ID: 21540627)
1. Cognitive-behavioral group therapy versus sertraline for obsessive-compulsive disorder: five-year follow-up.
Borges CP; Meyer E; Ferrão YA; Souza FP; Sousa MB; Cordioli AV
Psychother Psychosom; 2011; 80(4):249-50. PubMed ID: 21540627
[No Abstract] [Full Text] [Related]
2. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.
Asbahr FR; Castillo AR; Ito LM; Latorre MR; Moreira MN; Lotufo-Neto F
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1128-36. PubMed ID: 16239861
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.
Sousa MB; Isolan LR; Oliveira RR; Manfro GG; Cordioli AV
J Clin Psychiatry; 2006 Jul; 67(7):1133-9. PubMed ID: 16889458
[TBL] [Abstract][Full Text] [Related]
4. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
[TBL] [Abstract][Full Text] [Related]
5. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
Prazeres AM; Souza WF; Fontenelle LF
Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
[TBL] [Abstract][Full Text] [Related]
6. Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
Skarphedinsson G; Weidle B; Thomsen PH; Dahl K; Torp NC; Nissen JB; Melin KH; Hybel K; Valderhaug R; Wentzel-Larsen T; Compton SN; Ivarsson T
Eur Child Adolesc Psychiatry; 2015 May; 24(5):591-602. PubMed ID: 25239489
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
8. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Denys D
Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
[TBL] [Abstract][Full Text] [Related]
10. Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.
Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Dahl K; Nissen JB; Torp NC; Hybel K; Melin KH; Valderhaug R; Wentzel-Larsen T; Ivarsson T
J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):432-9. PubMed ID: 26091197
[TBL] [Abstract][Full Text] [Related]
11. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
[TBL] [Abstract][Full Text] [Related]
12. Sertraline in the treatment of obsessive-compulsive disorder.
Clary CM
Am Fam Physician; 1999 Jan; 59(1):49. PubMed ID: 9917574
[No Abstract] [Full Text] [Related]
13. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
Besiroglu L; Çetinkaya N; Selvi Y; Atli A
Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
[TBL] [Abstract][Full Text] [Related]
15. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
[TBL] [Abstract][Full Text] [Related]
16. Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder.
Skarphedinsson G; Weidle B; Ivarsson T
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):574-9. PubMed ID: 26348088
[TBL] [Abstract][Full Text] [Related]
17. Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study.
Jaurrieta N; Jimenez-Murcia S; Menchón JM; Del Pino Alonso M; Segalas C; Alvarez-Moya EM; Labad J; Granero R; Vallejo J
Psychother Res; 2008 Sep; 18(5):604-14. PubMed ID: 18816010
[TBL] [Abstract][Full Text] [Related]
18. Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
Rahman MS; Grace JJ; Pato MT; Priest B
Am J Psychiatry; 1998 Nov; 155(11):1629-30. PubMed ID: 9812137
[No Abstract] [Full Text] [Related]
19. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.
Lissemore JI; Sookman D; Gravel P; Berney A; Barsoum A; Diksic M; Nordahl TE; Pinard G; Sibon I; Cottraux J; Leyton M; Benkelfat C
Transl Psychiatry; 2018 Apr; 8(1):82. PubMed ID: 29666372
[TBL] [Abstract][Full Text] [Related]
20. Addition of trazodone to sertraline: a probable synergistic action in a case of obsessive-compulsive disorder.
Rocha FF; Corrêa H; Lage NV
Braz J Psychiatry; 2007 Dec; 29(4):381-2. PubMed ID: 18200402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
